MedTrace Logo

Real-World Study on the Burden of Hidradenitis Suppurativa

NCT07323303 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-01-07

No results posted yet for this study

Summary

Despite the significant impact of HS on patients' quality of life (QoL) and daily functioning, there remains limited real-world evidence describing the burden of this condition in Canada. HS is an under-recognized and often misdiagnosed condition, with a substantial psychological and physical burden on patients. Understanding the real-world experiences of individuals living with HS in Canada can help identify unmet needs and inform patient-centered care approaches.

Conditions

  • Hidradenitis Suppurativa (HS)

Interventions

OTHER

No Intervention: Observational Cohort

No specific intervention is assess in this study. Observational cohort.

Sponsors & Collaborators

  • PeriPharm

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-31
Primary Completion
2026-06-30
Completion
2026-07-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07323303 on ClinicalTrials.gov